Patent · US Active

Probiotic Bifidobacterium strain

US11225641B2 · kind B2 · utility

1Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 13, 2020
Grant dateJan 18, 2022
Priority date
Expiry dateFeb 13, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.